TGF-β-induced CD4+Foxp3+ T Cells Attenuate Acute Graft-Verse-host Disease Via Suppressing Expansion and Killing of Effector CD8+ Cells. (TRAN3P.875)

Song Guo Zheng,Jian Gu,Dongdong Chen,Julie Wang,Nancy Olsen
DOI: https://doi.org/10.4049/jimmunol.192.supp.202.14
2014-01-01
The Journal of Immunology
Abstract:Abstract TGF-β-induced CD4+Foxp3+ T cells (iTregs) have been identified as important treating strategies for cell therapy to autoimmune diseases and other disorders. However, the prevention effect of these cells on acute graft-verse-host disease (GVHD) has been unsatisfied because these cells are unstable and less suppressive in the disease. Here we restudied the ability of iTregs to prevent acute GVHD in two different mouse models. Our results showed that iTregs, as long as an appropriate protocol is used, they displayed a strong and consistent ability to control acute GVHD development and increase the survival in two different types of acute GVHD animal models. iTreg infusion markedly suppressed the engraftment of donor CD8+ cells, the expression of Granzyme A and B and cytotoxic effect of donor CD8+ cells, production of cytokines in T cells in acute GVHD. We therefore conclude that iTreg cells are able to prevent acute GVHD as long as the right methods for generating iTreg cells have been employed.
What problem does this paper attempt to address?